9-Azabicyclo[3.3.1]nonan-3-aMine, 9-Methyl-, hydrochloride (1:2)
- $45 - $330
- Product name: 9-Azabicyclo[3.3.1]nonan-3-aMine, 9-Methyl-, hydrochloride (1:2)
- CAS: 906081-58-1
- MF: C9H20Cl2N2
- MW: 227.1745
- EINECS:
- MDL Number:
- Synonyms:9-Azabicyclo[3.3.1]nonan-3-aMine, 9-Methyl-, hydrochloride (1:2);9-methyl-9-Azabicyclo[3.3.1]nonan-3-amine Dihydrochloride;Exo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonane DiHCl;9-Methyl-9-Azabicyclo[3.3.1]nonan-3-amine hydrochloride;9-Azabicyclo[3.3.1]nonan-3-aMine, 9-Methyl-, hydrochloride (1;3-Amino-9-methyl-9-azabicyclo[3.3.1]nonane Dihydrochloride
4 prices
Selected condition:
Brand
- Crysdot
- TRC
Package
- 25mg
- 50mg
- 100mg
- 5g
- ManufacturerCrysdot
- Product numberCD11020422
- Product description9-Methyl-9-azabicyclo[3.3.1]nonan-3-aminedihydrochloride 95+%
- Packaging5g
- Price$330
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberE959050
- Product descriptionExo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonaneDiHCl
- Packaging25mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberE959050
- Product descriptionExo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonaneDiHCl
- Packaging50mg
- Price$50
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberE959050
- Product descriptionExo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonaneDiHCl
- Packaging100mg
- Price$70
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11020422 | 9-Methyl-9-azabicyclo[3.3.1]nonan-3-aminedihydrochloride 95+% | 5g | $330 | 2021-12-16 | Buy |
TRC | E959050 | Exo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonaneDiHCl | 25mg | $45 | 2021-12-16 | Buy |
TRC | E959050 | Exo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonaneDiHCl | 50mg | $50 | 2021-12-16 | Buy |
TRC | E959050 | Exo-3-amino-9-methyl-9-azabicyclo[3.3.1]nonaneDiHCl | 100mg | $70 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|